Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus D Flather

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
BMC Medicine|April 5, 2019
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary diseaseDipak Kotecha, Marcus D Flather, Dan Atar, et al.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
European Journal of Heart Failure|March 2, 2026
Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trialsSebastian J Fox, Asgher Champsi, Evan J Hardy, et al.
International Journal of Cardiology|June 1, 2014
Effects of nebivolol on biomarkers in elderly patients with heart failureAnil K Taneja, David Gaze, Andrew J S Coats, et al.
European Journal of Heart Failure|March 2, 2026
Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysisKarina V Bunting, Otilia Tica, Asgher Champsi, et al.
European Heart Journal|November 16, 2004
Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK)Anil K Taneja, Julian Collinson, Marcus D Flather, et al.
Journal of the American Heart Association|May 5, 2017
Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST-Segment Elevation Myocardial InfarctionSujay Chandran, Johnathan Watkins, Amina Abdul-Aziz, et al.
European Heart Journal|June 25, 2008
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT studyRobert S Elkeles, Ian F Godsland, Michael D Feher, et al.
Heart (British Cardiac Society)|November 15, 2011
Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) studyAnita Saxena, Sivasubramanian Ramakrishnan, Ambuj Roy, et al.
Trials|December 3, 2013
A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocolMichael J Mullen, Marcus D Flather, Xu Yu Jin, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
BMC Medicine|April 5, 2019
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary diseaseDipak Kotecha, Marcus D Flather, Dan Atar, et al.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
European Journal of Heart Failure|March 2, 2026
Combination of heart failure and atrial fibrillation worsens ethnicity-related disparity: an individual patient-level meta-analysis of randomized trialsSebastian J Fox, Asgher Champsi, Evan J Hardy, et al.
International Journal of Cardiology|June 1, 2014
Effects of nebivolol on biomarkers in elderly patients with heart failureAnil K Taneja, David Gaze, Andrew J S Coats, et al.
European Journal of Heart Failure|March 2, 2026
Erythropoiesis-stimulating agents to reduce heart failure hospitalization: a systematic review and meta-analysisKarina V Bunting, Otilia Tica, Asgher Champsi, et al.
European Heart Journal|November 16, 2004
Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK)Anil K Taneja, Julian Collinson, Marcus D Flather, et al.
Journal of the American Heart Association|May 5, 2017
Inflammatory Differences in Plaque Erosion and Rupture in Patients With ST-Segment Elevation Myocardial InfarctionSujay Chandran, Johnathan Watkins, Amina Abdul-Aziz, et al.
European Heart Journal|June 25, 2008
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT studyRobert S Elkeles, Ian F Godsland, Michael D Feher, et al.
Heart (British Cardiac Society)|November 15, 2011
Prevalence and outcome of subclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) studyAnita Saxena, Sivasubramanian Ramakrishnan, Ambuj Roy, et al.
Trials|December 3, 2013
A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocolMichael J Mullen, Marcus D Flather, Xu Yu Jin, et al.
Pageof 8